Found: 17
Select item for more details and to access through your institution.
Influenza vaccine compatibility among hospitalized patients during and after the COVID-19 pandemic.
- Published in:
- Frontiers in Microbiology, 2024, p. 1, doi. 10.3389/fmicb.2023.1296179
- By:
- Publication type:
- Article
Omicron BA.2.75 variant is efficiently neutralised following BA.1 and BA.5 breakthrough infection in vaccinated individuals, Israel, June to September 2022.
- Published in:
- Eurosurveillance (15607917), 2022, v. 27, n. 44, p. 12, doi. 10.2807/1560-7917.ES.2022.27.44.2200785
- By:
- Publication type:
- Article
COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022.
- Published in:
- Eurosurveillance (15607917), 2022, v. 27, n. 30, p. 9, doi. 10.2807/1560-7917.es.2022.27.30.2200559
- By:
- Publication type:
- Article
The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021.
- Published in:
- Eurosurveillance (15607917), 2021, v. 26, n. 45, p. 4, doi. 10.2807/1560-7917.es.2021.26.45.2100974
- By:
- Publication type:
- Article
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel.
- Published in:
- Eurosurveillance (15607917), 2021, v. 26, n. 26, p. 9, doi. 10.2807/1560-7917.ES.2021.26.26.2100557
- By:
- Publication type:
- Article
Cocirculation of A(H3N2) and B/Victoria increased morbidity in hospitalized patients in the 2019–2020 A(H1N1)pdm09 predominant influenza season in Israel.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 2, p. 1, doi. 10.1002/jmv.28498
- By:
- Publication type:
- Article
Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022–2023 Winter Season.
- Published in:
- Vaccines, 2023, v. 11, n. 10, p. 1624, doi. 10.3390/vaccines11101624
- By:
- Publication type:
- Article
Disinfection of SARS-CoV-2 by UV-LED 267 nm: comparing different variants.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-35247-9
- By:
- Publication type:
- Article
Outbreak of Influenza and Other Respiratory Viruses in Hospitalized Patients Alongside the SARS-CoV-2 Pandemic.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.902476
- By:
- Publication type:
- Article
Tumor Treating Fields (TTFields) demonstrate antiviral functions in vitro, and safety for application to COVID-19 patients in a pilot clinical study.
- Published in:
- Frontiers in Microbiology, 2023, p. 1, doi. 10.3389/fmicb.2023.1296558
- By:
- Publication type:
- Article
Proof-of-concept for effective antiviral activity of an in silico designed decoy synthetic mRNA against SARS-CoV-2 in the Vero E6 cell-based infection model.
- Published in:
- Frontiers in Microbiology, 2023, p. 1, doi. 10.3389/fmicb.2023.1113697
- By:
- Publication type:
- Article
High Immune Response Rate to the Fourth Boost of the BNT162b2 Vaccine against the Omicron Variants of Concern among Liver Transplant Recipients.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 12, p. 2769, doi. 10.3390/v14122769
- By:
- Publication type:
- Article
Lytic Reactivation of the Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Is Accompanied by Major Nucleolar Alterations.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 8, p. 1720, doi. 10.3390/v14081720
- By:
- Publication type:
- Article
Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study.
- Published in:
- eLife, 2023, p. 1, doi. 10.7554/eLife.79946
- By:
- Publication type:
- Article
Hospital surveillance of respiratory viruses during the COVID-19 pandemic and beyond: contribution to the WHO mosaic framework, Israel, 2020 to 2023.
- Published in:
- Eurosurveillance (15607917), 2024, v. 29, n. 32, p. 1, doi. 10.2807/1560-7917.ES.2024.29.32.2300634
- By:
- Publication type:
- Article
Neutralization of SARS‐CoV‐2 variants elicited by the combination of vaccination and natural infection in heart transplant recipients.
- Published in:
- Clinical Transplantation, 2023, v. 37, n. 11, p. 1, doi. 10.1111/ctr.15092
- By:
- Publication type:
- Article
BNT162b2‐vaccine‐induced neutralization responses are immune correlates of clinical protection against SARS‐CoV‐2 in heart transplant recipients.
- Published in:
- Clinical Transplantation, 2023, v. 37, n. 11, p. 1, doi. 10.1111/ctr.15091
- By:
- Publication type:
- Article